文献速递肾移植肾血管病与高血压水电解质与酸碱

Gitelman 综合征供肾移植改善受者高血压:一例病例报告

Transplantation of a Gitelman Syndrome Kidney Ameliorates Hypertension: A Case Report.
PubMed 文献 · Am J Kidney Dis · 2018-09-07

本文报告一例 76 岁男性接受携带 SLC12A3 致病突变、已知 Gitelman 综合征的活体无关供肾移植。移植肾功能立即恢复,随后出现 Gitelman 综合征生化表型,血压改善,但受者发生意外低钠血症。作者讨论其可能机制,认为 Gitelman 综合征不应成为供肾禁忌,表型转移可能对受者有益。

要点

  • Gitelman 综合征供肾并非移植绝对禁忌,移植后表型可转移至受者。
  • 受者移植后出现 Gitelman 生化表型,血压改善,但发生意外低钠血症。
  • NCC 过度激活可能长期有利于血压控制并减轻钙调神经磷酸酶抑制剂毒性。

核心结论

  • Gitelman 综合征不应排除肾脏捐献,且表型转移可能对受者有益。

研究设计与样本

  • 单例病例报告:76 岁男性接受已知 Gitelman 综合征(SLC12A3 致病突变)供者的活体无关肾移植。

主要发现

  • 移植肾功能立即恢复,随后出现 Gitelman 综合征生化表型,血压随后改善。
  • 受者发生意外低钠血症,作者讨论其可能与噻嗪类诱导的高容量性低钠血症生理变化平行。
  • 供者与受者均保持健康。

临床怎么用

  • 临床可考虑将 Gitelman 综合征供肾用于特定受者,但需监测移植后生化表型及低钠血症。
  • 移植后 NCC 过度激活可能有助于血压控制并减轻钙调神经磷酸酶抑制剂相关副作用。

局限性

  • 单例病例报告,结论需更多研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Gitelman syndrome is caused by inactivating mutations of the gene that encodes the renal sodium/chloride cotransporter (NCC; encoded by SLC12A3), resulting in hypokalemia, hypomagnesemia, hypocalciuria, and metabolic alkalosis. Renal salt wasting commonly provokes mild hypotension. The paucity of previous kidney transplants from donors with known tubulopathies suggests that such conditions may be considered contraindications to donation. A 76-year-old man received a live unrelated kidney transplant from a donor with known Gitelman syndrome secondary to a pathogenic mutation of SLC12A3. Immediate graft function preceded the emergence of the Gitelman syndrome biochemical phenotype and blood pressure subsequently improved. The recipient developed unexpected hyponatremia. Potential causes are discussed, including the possibility that it paralleled the physiologic changes seen in the high-volume state of thiazide-induced hyponatremia. Transplanted kidneys are subject to nephrotoxicity from the use of calcineurin inhibitors. Acquired Gitelman syndrome may confer a potential long-term advantage to the recipient through both improved blood pressure control and protection against the calcineurin inhibitor-induced side-effect profile caused by NCC overactivation. Both the donor and recipient remain well. In conclusion, Gitelman syndrome need not preclude kidney donation and transference of the phenotype may have benefits for the recipient.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Stewart D, Iancu D, Ashton E, et al. Transplantation of a Gitelman Syndrome Kidney Ameliorates Hypertension: A Case Report. Am J Kidney Dis. 2018. PMID: 30201548. doi:10.1053/j.ajkd.2018.06.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。